William Burkes, MD
Sleep Medicine · Beaumont, TXNPI 1609879378
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $83,311 of the $99,417 with a category attached, or 83.8%. Harmony Biosciences LLC accounts for 95.9% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $32,325 and has fallen 93.2% since, to $2,187 in 2025. Among sleep medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 220 payments — averaging $451.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$95K
- ZOLL Respicardia, Inc.$2K
- Jazz Pharmaceuticals Inc.$1K
- Avadel CNS Pharmaceuticals, LLC$316
- Inspire Medical Systems, Inc.$237
- Merck$91
- plus $374 from 11 others
What the payments were for
- Consulting fees$4,0474%
- Speaking & faculty fees$83,31184%
- Travel & lodging$7,1777%
- Food & beverage$4,4644%
- Education$4170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 124 | $95,366 |
| ZOLL Respicardia, Inc. | 11 | $1,818 |
| Jazz Pharmaceuticals Inc. | 40 | $1,214 |
| Avadel CNS Pharmaceuticals, LLC | 16 | $316 |
| Inspire Medical Systems, Inc. | 5 | $237 |
| Merck | 6 | $91 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| Idorsia Pharmaceuticals US Inc | 3 | $60 |
| Eisai Inc. | 3 | $55 |
| Arbor Pharmaceuticals, Inc. | 2 | $40 |
| Biosense Webster, Inc. | 1 | $38 |
| Lilly USA, LLC | 1 | $20 |
| Itamar Medical Inc | 1 | $20 |
| AstraZeneca | 1 | $18 |
| Novo Nordisk | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wakix$93,721
- remede System$1,486
- XYWAV$150
- Inspire Upper Airway Stimulation System$119
How this compares
$99,417 in reported general payments places this provider in the 95th percentile of 112 sleep medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| WakixPitolisant Hcl | 18 | $384,724 |
| Sodium Oxybate | 17 | $302,454 |
| XywavSodium,calcium,mag,pot Oxybate | 12 | $240,097 |
| SunosiSolriamfetol Hcl | 14 | $12,205 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 48 | $2,158 |
| Ramelteon | 21 | $1,447 |
| Eszopiclone | 40 | $600 |
| Triazolam | 15 | $496 |
| Doxepin Hcl | 21 | $224 |
| Zolpidem Tartrate | 39 | $134 |
| Gabapentin | 26 | $115 |
| Alprazolam | 32 | $113 |
| Clonazepam | 18 | $81 |
| Diazepam | 13 | $64 |
| Temazepam | 22 | $57 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $95,366 | $384,72418 claims |
| Axsome Therapeutics, Inc.Sunosi | $80 | $12,20514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 112 sleep medicine providers in Texas.
Other sleep medicine in Beaumont
- Gerard MeskillSugar Land$1M
- Vikas JainFrisco$673K
- Amit VermaHouston$493K
- Jerald SimmonsHouston$165K
- James AndrySan Antonio$100K
- Ashwin GowdaAustin$71K
- John DebusDallas$38K
- Peter ObessoTyler$34K
- Karen Hentschel FranksSan Antonio$18K
- Bhavim DesaiAustin$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.